Pages that link to "Q44983136"
Jump to navigation
Jump to search
The following pages link to Efficacy of a 14-day primaquine regimen in preventing relapses in patients with Plasmodium vivax malaria in Mumbai, India (Q44983136):
Displaying 17 items.
- Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine (Q24202900) (← links)
- Primaquine for preventing relapses in people with Plasmodium vivax malaria (Q24246197) (← links)
- Primaquine in vivax malaria: an update and review on management issues (Q27003856) (← links)
- Epidemiology of Plasmodium vivax Malaria in India (Q28355353) (← links)
- Resistance to therapies for infection by Plasmodium vivax (Q33481576) (← links)
- Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India (Q33612286) (← links)
- Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries (Q33695141) (← links)
- Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects. (Q34010618) (← links)
- Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax (Q34252526) (← links)
- Age-dependent sex bias in clinical malarial disease in hypoendemic regions (Q34256505) (← links)
- Primaquine and relapses of Plasmodium vivax. Meta analysis of controlled clinical trials (Q35555054) (← links)
- Effect of seasonality and ecological factors on the prevalence of the four malaria parasite species in northern mali (Q35864128) (← links)
- Neglected Plasmodium vivax malaria in northeastern States of India (Q35877848) (← links)
- Prospective Study of Plasmodium vivax Malaria Recurrence after Radical Treatment with a Chloroquine-Primaquine Standard Regimen in Turbo, Colombia (Q37120100) (← links)
- KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro (Q37643622) (← links)
- Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial (Q48016667) (← links)
- Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname (Q48021415) (← links)